BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16153617)

  • 21. Computational analysis of the R85C and R85H epilepsy mutations in Na+ channel beta1 subunits.
    Thomas EA; Xu R; Petrou S
    Neuroscience; 2007 Jul; 147(4):1034-46. PubMed ID: 17604911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
    Decher N; Kumar P; Gonzalez T; Renigunta V; Sanguinetti MC
    Mol Pharmacol; 2005 Oct; 68(4):995-1005. PubMed ID: 16024663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elementary properties of Kir2.1, a strong inwardly rectifying K(+) channel expressed by pigeon vestibular type II hair cells.
    Zampini V; Masetto S; Correia MJ
    Neuroscience; 2008 Sep; 155(4):1250-61. PubMed ID: 18652879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism.
    Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):227-37. PubMed ID: 11561084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms underlying modulation of neuronal KCNQ2/KCNQ3 potassium channels by extracellular protons.
    Prole DL; Lima PA; Marrion NV
    J Gen Physiol; 2003 Dec; 122(6):775-93. PubMed ID: 14638935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zn(2+) slows down Ca(V)3.3 gating kinetics: implications for thalamocortical activity.
    Cataldi M; Lariccia V; Marzaioli V; Cavaccini A; Curia G; Viggiano D; Canzoniero LM; di Renzo G; Avoli M; Annunziato L
    J Neurophysiol; 2007 Oct; 98(4):2274-84. PubMed ID: 17699699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and biophysical properties of Kv1 channels in supragranular neocortical pyramidal neurones.
    Guan D; Lee JC; Tkatch T; Surmeier DJ; Armstrong WE; Foehring RC
    J Physiol; 2006 Mar; 571(Pt 2):371-89. PubMed ID: 16373387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coumarsabin hastens C-type inactivation gating of voltage-gated K⁺ channels.
    Chen YH; Wu KC; Yang CT; Tu YK; Gong CL; Chao CC; Tsai MF; Kuo YH; Leung YM
    Eur J Pharmacol; 2013 Mar; 704(1-3):41-8. PubMed ID: 23420002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane tension accelerates rate-limiting voltage-dependent activation and slow inactivation steps in a Shaker channel.
    Laitko U; Morris CE
    J Gen Physiol; 2004 Feb; 123(2):135-54. PubMed ID: 14744987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical simulations of the effects of altered AMP-kinase activity on I and the action potential in rat ventricle.
    Bazzazi H; Clark RB; Giles WR
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S162-S168. PubMed ID: 16686674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
    Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of Kv1 channel-mediated currents by co-expression of Kvbeta3 subunit in a mammalian cell-line.
    Bähring R; Vardanyan V; Pongs O
    Mol Membr Biol; 2004; 21(1):19-25. PubMed ID: 14668135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A direct demonstration of closed-state inactivation of K+ channels at low pH.
    Claydon TW; Vaid M; Rezazadeh S; Kwan DC; Kehl SJ; Fedida D
    J Gen Physiol; 2007 May; 129(5):437-55. PubMed ID: 17470663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of amiodarone on Kv1.4 channel C-type inactivation: comparison of its effects with those induced by propafenone and verapamil.
    Xu L; Huang C; Chen J; Jiang X; Li X; Bett GC; Rasmusson RL; Wang S
    Pharmazie; 2008 Jun; 63(6):475-9. PubMed ID: 18604993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Position-dependent attenuation by Kv1.6 of N-type inactivation of Kv1.4-containing channels.
    Al-Sabi A; Kaza S; Le Berre M; O'Hara L; Bodeker M; Wang J; Dolly JO
    Biochem J; 2011 Sep; 438(2):389-96. PubMed ID: 21352098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic inhibition of the maximum conductance of Kv1.5 channels by extracellular K+ reduction and acidification.
    Fedida D; Zhang S; Kwan DC; Eduljee C; Kehl SJ
    Cell Biochem Biophys; 2005; 43(2):231-42. PubMed ID: 16049348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of increased open probability by a mutation of the BK channel.
    Díez-Sampedro A; Silverman WR; Bautista JF; Richerson GB
    J Neurophysiol; 2006 Sep; 96(3):1507-16. PubMed ID: 16738211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
    Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
    Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Length-dependent regulation of the Kv1.2 channel activation by its C-terminus.
    Zhao LL; Wu A; Bi LJ; Liu P; Zhang XE; Jiang T; Jin G; Qi Z
    Mol Membr Biol; 2009 Apr; 26(3):186-93. PubMed ID: 19247844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional changes in genetically dysmyelinated spinal cord axons of shiverer mice: role of juxtaparanodal Kv1 family K+ channels.
    Sinha K; Karimi-Abdolrezaee S; Velumian AA; Fehlings MG
    J Neurophysiol; 2006 Mar; 95(3):1683-95. PubMed ID: 16319208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.